Neureka for Epilepsy

Neureka for Epilepsy

Early Stage

Epilepsy care reimagined

Epilepsy care reimagined

Overview

Raised this Round: Raised: $87,101

Total Commitments ($USD)

Platform

Republic

Start Date

02/13/2023

Close Date

04/15/2023

Min. Goal
$25,000
Max. Goal
$1,235,000
Min. Investment

$150

Security Type

SAFE

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Valuation Cap

$25,000,000

Discount

20%

Year Founded

2018

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B/B2C

Margin

Low

Capital Intensity

Low

Location

Alameda, California

Business Type

Growth

Neureka for Epilepsy, with a valuation of $25 million, is raising funds on Republic. The company provides AI-powered wearable devices for on-demand epilepsy care. The wearable device captures health data, connects patients with their care teams, and empowers doctors with data to make better treatment decisions. Neureka for Epilepsy is backed by ten years of R&D and is accelerating its epilepsy center partnerships and B2C market traction. Ray Iskander and Parisa Sabetian founded Neureka for Epilepsy in February 2018. The current crowdfunding campaign has a minimum target of $25,000 and a maximum target of $1.24 million. The campaign proceeds will be used for new product marketing, research and development, new hires, and general working capital.

Summary Profit and Loss Statement

FY 2021 FY 2020

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-1,393,497

$-962,316

Summary Balance Sheet

FY 2021 FY 2020

Cash

$281,299

$64,459

Accounts Receivable

$0

$0

Total Assets

$286,340

$71,179

Short-Term Debt

$50,065

$34,704

Long-Term Debt

$20,171

$42,167

Total Liabilities

$70,236

$76,871

Financials as of: 02/13/2023
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Neureka for Epilepsy on Republic 2023
Platform: Republic
Security Type: SAFE
Valuation: $25,000,000

Follow company

Follow Neureka for Epilepsy on Republic 2023

Buy Neureka for Epilepsy's Deal Report

Warning: according to the close date for this deal, Neureka for Epilepsy may no longer be accepting investments.

Neureka for Epilepsy Deal Report

Get KingsCrowd’s comprehensive report on Neureka for Epilepsy including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Neureka for Epilepsy is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Neureka for Epilepsy deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge